Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 7/20 | 0.62 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.62 |
| ▸ | TFPI | P10646 | 4/20 | 0.59 |
| ▸ | APLNR | P35414 | 3/20 | 0.58 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.57 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.57 |
| ▸ | KDM1A | O60341 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30359266 | 0.92 | APLNR (0.64) | OPRM1OPRK1TFPIAPLNRNMUR2 | |
| SCHEMBL30359268 | 0.92 | APLNR (0.64) | OPRM1OPRK1TFPIAPLNRNMUR2 | |
| SCHEMBL30359269 | 0.92 | APLNR (0.64) | OPRM1OPRK1TFPIAPLNRNMUR2 | |
| SCHEMBL30359271 | 0.92 | APLNR (0.64) | OPRM1OPRK1TFPIAPLNRNMUR2 | |
| SCHEMBL19706377 | 0.87 | APLNR (0.65) | TFPIAPLNRNMUR2NMUR1 | |
| SCHEMBL30359263 | 0.87 | APLNR (0.58) | OPRM1OPRK1TFPIAPLNRNMUR2 | |
| SCHEMBL29416002 | 0.85 | NMUR2 (0.65) | OPRM1OPRK1TFPIAPLNRNMUR2 | |
| SCHEMBL30527874 | 0.85 | NMUR2 (0.65) | OPRM1OPRK1TFPIAPLNRNMUR2 | |
| SCHEMBL29973451 | 0.85 | NMUR2 (0.60) | OPRM1OPRK1NMUR2NMUR1 | |
| SCHEMBL30402818 | 0.84 | NMUR2 (0.66) | OPRM1NMUR2NMUR1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3237435-B1 | METABOLICALLY STABLE APELIN ANALOGS IN THE TREATMENT OF DISEASE MEDIATED BY THE APELIN RECEPTOR | INST NAT SANTE RECH MED (FR) | 2023-05-24 | — | — | EP | disclosed |